rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

530239 SUVEN Group (B)

Suven Life Sciences Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
318.25   -6.35   -1.96%
Volume 179,712
Prev close 324.60
Day's H/L (Rs.) 329.85 - 315.30
52wk H/L (Rs.) 338.50 - 74.10
Mkt Cap (Rs. Cr) 4,051.32
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

SUVEN

Suven Life Sciences Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
318.55   -6.25   -1.92%
Volume 822,478
Prev close 324.80
Day's H/L (Rs.) 329.80 - 315.55
52wk H/L (Rs.) 338.50 - 74.05
Turnover (Rs. Lacs) 2,659.81
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Suven Life Sciences Ltd.  (See all 695 market voices)   

140 Characters
  Cancel
Ff - 1 day(s) ago just hold mr. parkinson, then u will get fits, enjoy
#Suven-Life-Sciences-Ltd
Reply   |   Share
sunrays - 1 day ago  what mr ebola next target ???
Reply   |  Share
sunrays - 1 day ago  clinicla trails for mr ebola is under going @ indian Pharma companies..
Reply   |  Share
sunrays - 1 day ago  Hye Mr ebola did U watch Chriss Gale out @95 by viewing anushka in last match
Reply   |  Share
Sunrays - 1 day(s) ago any body watched Chriss Gale out @95 by viewing anushka in last match
#Suven-Life-Sciences-Ltd
Reply   |   Share

Realtime news for Suven Life Sciences Ltd. (See all 207 news)

18 April 2015, 20:33
Suven Life up 4%, begins clinical trials of alzheimer drug - 5 day(s) ago
Suven's Alzheimer's drug candidate clears single-dose studies - 5 day(s) ago
Suven to invest $25 mn to test Alzheimer's drug - 09 Apr 2015
Suven Life Sciences targets 10-15% revenue growth in FY16: Venkat Jasti - 17 Feb 2015
Suven Life shares zoom 20% on getting patent for drug - 16 Mar 2015

BSE Announcements from Suven Life Sciences Ltd. (See all)

Shareholding Pattern For March 31, 2015 - 2 day(s) ago
Suven initiated Multiple Ascending Dose (MAD) studies in Phase 1 clinical Trial for their investigational compound SUVN-G3031 - 5 day(s) ago

Company details for Suven Life Sciences Ltd.

Report Card

PE Ratios
26.31
EPS (Rs.)
12.34
Sales (Rs. Cr)
128.83
Face Value (Rs.)
1
Net Profit
Margin (%)
 
28.08
Last Bonus
1:1
Last Dividend(%)
200
Return on
Average Equity
 
54.51

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Suven Life Sciences Ltd. performance snapshot

If you had invested Rs.  in Suven Life Sciences Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Suven Life Sciences Ltd. with other stocks

Ranbaxy Laboratories Ltd.
814.10
Ajanta Pharma Ltd.
1,412.15
Show more companies
Ranbaxy Laboratories Ltd.
814.10
Ajanta Pharma Ltd.
1,412.15
Alembic Pharmaceuticals Ltd.
480.00
Apollo Hospitals Enterprise Ltd.
1,375.70
Aurobindo Pharma Ltd.
1,415.60
Biocon Ltd.
471.00
Cadila Healthcare Ltd.
1,788.40
Cipla Ltd.
678.75
Divi's Laboratories Ltd.
1,888.90
Dr. Reddy's Laboratories Ltd.
3,681.45
Show less companies
Close
Add Suven Life Sciences Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Life Sciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close